These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 7912626)

  • 21. 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 Nov; 164(2):214-20. PubMed ID: 12404085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of 5-HT2A, 5-HT2B and 5-HT2C receptors in mediating the ventrolateral orbital cortex-induced antiallodynia in a rat model of neuropathic pain.
    Xu WJ; Wang YY; Zhao Y; Jia H; Tang JS; Huo FQ; Liu H
    Neuroreport; 2020 Jan; 31(2):167-173. PubMed ID: 31789691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
    Dekeyne A; Girardon S; Millan MJ
    Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine.
    Bourson A; Wanner D; Wyler R; Petit N; Zwingelstein C; Rudler A; Sleight AJ
    Pharmacol Biochem Behav; 1996 Jan; 53(1):107-14. PubMed ID: 8848438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wistar-Kyoto rats are sensitive to the hypolocomotor and anxiogenic effects of mCPP.
    Durand M; Mormède P; Chaouloff F
    Behav Pharmacol; 2003 Mar; 14(2):173-7. PubMed ID: 12658079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-maze.
    Mora PO; Netto CF; Graeff FG
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1051-7. PubMed ID: 9408213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.
    Rosenzweig-Lipson S; Zhang J; Mazandarani H; Harrison BL; Sabb A; Sabalski J; Stack G; Welmaker G; Barrett JE; Dunlop J
    Brain Res; 2006 Feb; 1073-1074():240-51. PubMed ID: 16430874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes.
    Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
    Neuropharmacology; 2004 Apr; 46(5):663-71. PubMed ID: 14996544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential.
    Martin JR; Bös M; Jenck F; Moreau J; Mutel V; Sleight AJ; Wichmann J; Andrews JS; Berendsen HH; Broekkamp CL; Ruigt GS; Köhler C; Delft AM
    J Pharmacol Exp Ther; 1998 Aug; 286(2):913-24. PubMed ID: 9694950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the 5-HT2C receptor in improving weight-supported stepping in adult rats spinalized as neonates.
    Kao T; Shumsky JS; Jacob-Vadakot S; Himes BT; Murray M; Moxon KA
    Brain Res; 2006 Sep; 1112(1):159-68. PubMed ID: 16914121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists.
    Vickers SP; Easton N; Malcolm CS; Allen NH; Porter RH; Bickerdike MJ; Kennett GA
    Pharmacol Biochem Behav; 2001; 69(3-4):643-52. PubMed ID: 11509227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
    Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent.
    Bromidge SM; Dabbs S; Davies DT; Davies S; Duckworth DM; Forbes IT; Gaster LM; Ham P; Jones GE; King FD; Mulholland KR; Saunders DV; Wyman PA; Blaney FE; Clarke SE; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Trail B; Riley GJ; Wood MD
    J Med Chem; 2000 Mar; 43(6):1123-34. PubMed ID: 10737744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
    Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ
    Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse.
    Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
    Psychopharmacology (Berl); 2006 Mar; 185(1):45-57. PubMed ID: 16470405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
    Willins DL; Meltzer HY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cataleptogenic effect of subtype selective 5-HT receptor antagonists in the rat.
    Kalkman HO; Neumann V; Nozulak J; Tricklebank MD
    Eur J Pharmacol; 1998 Feb; 343(2-3):201-7. PubMed ID: 9570468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directly Observable Behavioral Effects of Lorcaserin in Rats.
    Serafine KM; Rice KC; France CP
    J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of adrenodemedullation and adrenalectomy on the 5-HT2 receptor agonists DOI-and mCPP-induced hypophagia in rats.
    Yamada J; Sugimoto Y; Yoshikawa T; Horisaka K
    Neurosci Lett; 1996 May; 209(2):113-6. PubMed ID: 8761995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.